Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

Eli Lilly is wasting no time in pursuit of the next indication for its newly christened obesity pill Foundayo, presenting new ...

Learn why GLP-1 use isn’t included in how experts define type 2 diabetes remission despite the drugs’ ability to help manage blood sugar and reduce a person’s A1C.

Lilly plans to file Foundayo with the FDA for type 2 diabetes by end of Q2 after the ACHIEVE-4 trial met its primary ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

The approval of medicines called “glucagon-like peptide (GLP-1) agonists” has led to major changes in how type 2 diabetes is managed. These medicines work in a different way than other medicines used ...

A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

A new study examines the role of palmitic acid and oleic acid—among the main fatty acids in the diet—in the development of ...

If you have type 2 diabetes, it’s important to manage your hormone levels, as an imbalance can alter how your body responds to insulin. Lifestyle measures like reducing stressors and eating a balanced ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes. Monitoring blood glucose levels is ...

A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...